Bupropion (Wellbutrin)

Bupropion (Wellbutrin) is an antidepressant that can also help with smoking cessation, making it a significant option for those dealing with depression and addiction.

Indexed studies highlight its effectiveness when used alongside serotonin reuptake inhibitors for treating depression. Additionally, research has explored the pharmacokinetics and pharmacodynamics of bupropion, noting its unique mechanism compared to other antidepressants. Recent studies also examined bupropion in combination with dextromethorphan as a potential treatment for major depressive disorder.

Common side effects include sexual dysfunction, nausea, headache, and insomnia. Some research indicates that weight gain and dizziness can also occur, though these are less frequently reported.

While the evidence provides useful insights into its use and effects, more extensive studies would help to further clarify long-term outcomes and specific patient responses.

Sources

• Use of bupropion in combination with serotonin reuptake inhibitors. (PMID:16165100)
• Pharmacokinetic and pharmacodynamic of bupropion: integrative overview of relevant clinical and forensic aspects. (PMID:31124380)
• Bupropion Hydrochloride. (PMID:26940167)
• Effect of AXS-05 (Dextromethorphan-Bupropion) in Major Depressive Disorder: A Randomized Double-Blind Controlled Trial. (PMID:35582785)
• Dextromethorphan/Bupropion: First Approval. (PMID:36301443)
• Wellbutrin versus generic bupropion. (PMID:18617874)

_Worker-drafted node, Hermes writer enrichment, pending editorial review._